Concepedia

Yuan Liu

YL

32

Publications

3K

Citations

20

H-Index

2013

Active since

Affiliations

Pfizer (United States)(Current)

Institute of Cancer Research

Royal Marsden Hospital

Institut Gustave Roussy

Peter MacCallum Cancer Centre

Yuan Liu is an author at Pfizer (United States) specializing in medicine, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

2013–2024

32

Publications

32

The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial

Ben O’Leary, Rosalind Cutts, Yuan Liu et al. · Cancer Discovery · 2018 · 642 citations · Full text

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer

Nicholas C. Turner, Yuan Liu, Zhou Zhu et al. · Journal of Clinical Oncology · 2019 · 435 citations · Full text

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Ben O’Leary, Sarah Hrebien, James P. Morden et al. · Nature Communications · 2018 · 404 citations · Full text

Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial

Toni K. Choueiri, David J. Figueroa, André P. Fay et al. · Clinical Cancer Research · 2014 · 242 citations · Full text

Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study

Massimo Cristofanilli, Hope S. Rugo, Seock‐Ah Im et al. · Clinical Cancer Research · 2022 · 185 citations · Full text

Rows per page

1–5 of 32